Video

How Hepatitis C Therapies are Changing Patient Treatment

Eric Tichy, PharmD, BCPS, FCCP, senior clinical pharmacy specialist at Yale New-Haven Hospital, explains how hepatitis C therapies are changing patient treatment.

Eric Tichy, PharmD, BCPS, FCCP, senior clinical pharmacy specialist at Yale New-Haven Hospital, explains how hepatitis C therapies are changing patient treatment.

This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image Credit: shidlovski | stock.adobe.com
Related Content
RSV vaccine vial with syringe - Respiratory syncytial virus shot - Image credit: MargJohnsonVA | stock.adobe.com
September 17th 2025

Study Shows AOV System Reduces Errors in RSV Vaccine Preparation

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus Oncology Edition Podcast
September 17th 2025

Protecting Community Oncology Practices in the Wake of the IRA

Alexandra Gerlach, Associate Editor
Cutting Psychedelic Thai Cubensis Mushrooms For Spore Prints | Image Credit: Ayehab | stock.adobe.com
September 17th 2025

Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act

Jillian Hernandez, MS Andrew Krut, PharmD, RPh Kristin Speer, PharmD, BCPS, RPh Justin Belko, BS
From Guidelines to Action: Pharmacy’s Role in Hypertension Management
September 17th 2025

From Guidelines to Action: Pharmacy’s Role in Hypertension Management

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Vaccine for the virus. Medical ampoules on a chessboard, defeat the king. Concept cure for coronavirus.
September 17th 2025

Op-Ed: Vaccine Policy Changes Are Undoing Pharmacy Access

Spreeha Choudhury, PharmD, JD Richard Hughes IV, JD, MPH
Doctor measuring overweight boy in clinic - Image credit: Africa Studio | stock.adobe.com
September 17th 2025

Study Highlights Benefits, Safety Considerations of GLP-1s in Children and Adolescents With T2D or Obesity

Kennedy Ferruggia, Assistant Editor
© 2025 MJH Life Sciences

All rights reserved.